
Corporate
Pyxis Oncology CEO Sullivan Steps Down After 88% Stock Plunge, Board Member Takes Reins
14h ago
You're signed outSign in or to get full access.
View earnings summary and analysis
View earnings summary and analysis
View earnings summary and analysis
View earnings summary and analysis
Research analysts covering Pyxis Oncology.